articleThe LancetApr 4, 2012Closed access

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

AEAndreas EngertHHHeinz HaverkampCKCarsten KobeJMJana MarkováCRChristoph Renner

University Hospital Cologne · University Hospital Kralovske Vinohrady · +22 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

631
total citations
FWCI
35.92
Percentile
100%
References
35
Citations per year

Authors

31

Topics & keywords

Topics
Keywords
  • Medicine
  • Clinical endpoint
  • Hazard ratio
  • Radiation therapy
  • Chemotherapy
  • Regimen
  • Randomized controlled trial
  • Chemotherapy regimen
UN Sustainable Development Goals
  • Peace, Justice and strong institutions
No related works found for this paper.

Funding